Patient feedback so far shows that although most folks dig the accelerated weight loss speed, others experience early side effects, particularly GI ones, which can occasionally decelerate or even halt momentum
Am J Physiol Renal Physiol (2021) 320(3):F454F63
"New treatment options bring hope to the many people with obesity who struggle with this disease and are seeking better options for weight management," Joe Nadglowski, CEO of the Obesity Action Coalition, said in Eli Lilly's release
For women with pre-existing conditions such as PCOS, endometriosis, or fibroids, discussing how GLP-1 medications might interact with these conditions before starting treatment is advisable
This guide walks through every way to access retatrutide today (clinical trials, expanded access, research peptides), explains the legal and safety landscape, and covers what you can do while waiting